Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mimglobin
- Development stage
- Unknown
- Lead developer
- Meyer Organics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mimglobin (also known as Mimglobin Liquid) is an oral haematinic and nutritional supplement developed by Meyer Organics. It is formulated as a liquid syrup containing a combination of elemental iron (as ferric ammonium citrate), elemental zinc, essential amino acids (L-histidine and L-lysine), and a comprehensive B-vitamin complex (including vitamins B1, B2, B3, B5, B6, B9/folic acid, and B12/cyanocobalamin). Mimglobin is indicated for the prevention and treatment of iron-deficiency anemia, particularly during pregnancy, lactation, menstruation, and post-surgical convalescence. It works by providing the essential building blocks required for hemoglobin synthesis, red blood cell production, and cellular energy metabolism.
- Brand names
- Dr. Meyer's Mim Globin LiquidMeyer's Mim Globin LiquidMimglobinMimglobin Liquid
Beyond the preview
Go deeper on Mimglobin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mimglobin.